Clinical trial

Target-specific immunoPET Imaging of Breast Cancer

NCT06715826

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-21

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2024-09-21Date precision: day

Registry last updated2026-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Neoplasmsunresolved

Breast Cancer Metastaticunresolved

Interventions

[18F]F-RESCA-RT4DRUG

[18F]F-RESCA-RB14DRUG

Sponsors & collaborators

RenJi Hospitallead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06715826 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.